Cleared Traditional

K202231 - JADE (FDA 510(k) Clearance)

Dec 2020
Decision
125d
Days
Class 2
Risk

K202231 is an FDA 510(k) clearance for the JADE. This device is classified as a Catheter, Angioplasty, Peripheral, Transluminal (Class II - Special Controls, product code LIT).

Submitted by OrbusNeich Medical (Shenzhen) Co., Ltd. (Shenzhen, CN). The FDA issued a Cleared decision on December 10, 2020, 125 days after receiving the submission on August 7, 2020.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1250.

Submission Details

510(k) Number K202231 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 07, 2020
Decision Date December 10, 2020
Days to Decision 125 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code LIT - Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1250

Similar Devices - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 9
Armada™ 14 NC PTA Catheter
K252512 · Abbott Medical · Feb 2026
Passeo-35 Xeo Peripheral Dilatation Catheter
K250706 · Biotronik, Inc. · Apr 2025
Oscar Peripheral Multifunctional Catheter system
K241711 · Biotronik, Inc. · Jul 2024
Sterling™ MONORAIL™ PTA Balloon Dilatation Catheter (H74939031404020 )
K241683 · Boston Scientific Corporation · Jul 2024
Passeo-35 Xeo Peripheral Dilatation Catheter
K222065 · Biotronik, Inc. · Feb 2023
Highlander™ 014 PTA Balloon Dilatation Catheter
K223177 · C.R. Bard, Inc. · Jan 2023